MYLS22
| Supplier | MedChemExpress |
|---|---|
| Product # | HY-136446-50 mg |
| CAS # | 306959-01-3 |
| Pricing | 50 mg, USD $280.0 |
| Biological Activity | MYLS22 is a first-in-class and selective optic atrophy 1 (OPA1) inhibitor. MYLS22 can target endothelial OPA1 to curtail tumor growth and inhibits angiogenesis by impinging on NFkB activity and on angiogenic gene expression[1]. |
| Purity | 98.51% |
| MWt | 443.52 |
| Formula | C₂₄H₂₁N₅O₂S |